Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis

Abstract Background Comorbid autoimmune disorders, including rheumatoid arthritis (RA), are common in people with multiple sclerosis (MS). Both conditions share pathogenic similarities, enabling potential overlap in treatments. While numerous disease-modifying therapies (DMT) are approved for MS and...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Franz Felix Konen, Torsten Witte, Diana Ernst, David Hagin, Konstantin Fritz Jendretzky, Nora Möhn, Sandra Nay, Lea Grote-Levi, Kurt-Wolfram Sühs, Luisa Klotz, Steffen Pfeuffer, Refik Pul, Christoph Kleinschnitz, Marc Pawlitzki, Sven G. Meuth, Thomas Skripuletz
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2025-07-01
سلاسل:	Neurological Research and Practice
الموضوعات:	Multiple sclerosis Rheumatoid arthritis Disease-modifying therapy Autoimmune disorders Treatment Beneficial and adverse effects
الوصول للمادة أونلاين:	https://doi.org/10.1186/s42466-025-00414-y
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!